share_log

CASI Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-WEI-WU HE, Ph.D.(18.95%),EMERGING TECHNOLOGY PARTNERS, LLC(8.89%), etc.

CASI制药 | SC 13D/A:超过5%持股股东披露文件(修正)-WEI-WU HE, Ph.D.(18.95%),EMERGING TECHNOLOGY PARTNERS, LLC(8.89%)等

美股SEC公告 ·  2022/06/21 16:26
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息